$TEVA News Article - Teva Announces the Launch of the First Generic Version of Absorica (isotretinoin) Capsules, for the Treatment of Severe Recalcitrant Nodular Acne in Patients 12 Years of Age and Older, in the United States
https://marketwirenews.com/news-releases/teva...50589.html